Regarding PD-1 expression, our results agree with those of Tan et al. [45], showing an increased percentage of CD8+ T cells expressing PD-1 in AML patients compared with healthy donors and support the role of PD-1 as a biomarker of T cell exhaustion. This evidence concerns the gene CD8A and acute myeloid leukemia.